Cincinnati Enquirer: Lost sense of smell among coronavirus symptoms
UC expert in diseases of the ear, nose and throat researching link
Ear, Nose and Throat specialists across the nation are seeing an uptick in patients showing up with decreased or completely lost sense of smell in conjunction with the arrival of the conoravirus. It may be a clue in identifying individuals who are impacted by this virus.
Ahmad Sedaghat, MD, PhD, associate professor in the University of Cincinnati College of Medicine and an Ear, Nose and Throat specialist at UC Health, is performing research in this area of coronavirus-associated smell loss in close collaboration with other experts. He spoke with the Cincinnati Enquirer about this emerging area of interest associated with COVID-19.
"If you experience a decrease or complete loss of the sense of smell with no nasal obstruction – that's according to doctors coming out of Europe – the odds are incredibly high that you are infected with the novel coronavirus," Sedaghat told a reporter for the Enquirer.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.